Sequence information
Variant position: 318 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 360 The length of the canonical sequence.
Location on the sequence:
RSHSWLESCIVGWRCRVGQW
V RMENVTVLGEDVIVNDELYL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human RSHSWLESCIVGWRCRVGQWV RMENVTVLGEDVIVNDELYL
Mouse RSHSWLESCIVGWRCRVGQWV RMENVTVLGEDVIVNDELYL
Pig RSHSWLESCIVCWRCRVGQWV RMENVTVLGEDVIVNDELYL
Bovine RSHSWLESCIVGWRCRVGQWV RMENVTVLGEDVIVNDELYL
Xenopus tropicalis HSHSWLESSIVGWSSSVGQWV RMENVTVLGEDVIVNDELYL
Zebrafish RSHSWLESCIVGWSSSVGQWV RMENVTVLGEDVIVNDELYI
Caenorhabditis elegans GNYSWVSGSIVGRKCHIGSWV RIENICVIGDDVVVKDELYL
Drosophila RSHSWLDSCIVGWRSTVGRWV RIEGITVLGEDVIVKDELYI
Slime mold GKNSWIKSTIIGWNSSIGKWV RMENTSVLGEDVHVSDELYI
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 360
Mannose-1-phosphate guanyltransferase beta
Alternative sequence
317 – 317
W -> WVSLWAGLGGERGGECACLPDKAYPLLE. In isoform 2.
Literature citations
GMPPB-associated dystroglycanopathy: Emerging common variants with phenotype correlation.
Jensen B.S.; Willer T.; Saade D.N.; Cox M.O.; Mozaffar T.; Scavina M.; Stefans V.A.; Winder T.L.; Campbell K.P.; Moore S.A.; Mathews K.D.;
Hum. Mutat. 36:1159-1163(2015)
Cited for: VARIANTS MDDGC14 HIS-27; SER-32; CYS-132; THR-219; SER-241; MET-254; GLN-287; TRP-287; ALA-318 AND ILE-330;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.